Jacqueline J. Loonen

Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity

Elizabeth A. M. Feijen, Wendy M. Leisenring, Kayla Stratton et al. · JAMA Oncology · 2019 · 240 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy

Jop C. Teepen, Flora E. van Leeuwen, Wim J. E. Tissing et al. · Journal of Clinical Oncology · 2017 · 224 citations · Full text

Medicine, Oncology, Pediatrics +17

Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study

Elizabeth A. M. Feijen, Anna Font‐Gonzalez, Helena J. H. van der Pal et al. · Journal of the American Heart Association · 2018 · 112 citations · Full text

Medicine, Oncology, Pediatrics +17

Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study

Annelies M. C. Mavinkurve‐Groothuis, Karen A. Marcus, M. Pourier et al. · European Heart Journal - Cardiovascular Imaging · 2012 · 101 citations

Medicine, Oncology, Pediatrics +16

Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study

Eva Clemens, Andrica de Vries, Saskia F.M. Pluijm et al. · European Journal of Cancer · 2016 · 98 citations

Medicine, Oncology, Otolaryngology +16